# Mercury General Corp: financial statements, quarterly

MCY · NYSE · CIK 64996 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mcy.md) · [Financials](/companies/mcy/financials.md) · [Filings](/companies/mcy/filings.md) · [Insiders](/companies/mcy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mcy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,065](/filings/0000064996-24-000027.md) | [1,375 d](/filings/0000064996-26-000005.md) | [1,274](/filings/0000064996-25-000028.md) | [1,305](/filings/0000064996-25-000041.md) | [1,530](/filings/0000064996-25-000044.md) | [1,366 d](/filings/0000064996-26-000005.md) | [1,394](/filings/0000064996-26-000014.md) | [1,478](/filings/0000064996-26-000020.md) | [1,585](/filings/0000064996-25-000044.md) | [1,536 d](/filings/0000064996-26-000005.md) | [1,540](/filings/0000064996-26-000014.md) | [1,682](/filings/0000064996-26-000020.md) |
| Cost of revenue | $m | [2.7](/filings/0000064996-24-000027.md) | [3.2 d](/filings/0000064996-26-000005.md) | [3.2](/filings/0000064996-25-000028.md) | [3.2](/filings/0000064996-25-000041.md) | [3.2](/filings/0000064996-25-000044.md) | [3.8 d](/filings/0000064996-26-000005.md) | [3.6](/filings/0000064996-26-000014.md) | [3.6](/filings/0000064996-26-000020.md) | [3.9](/filings/0000064996-25-000044.md) | [4.1 d](/filings/0000064996-26-000005.md) | [4.4](/filings/0000064996-26-000014.md) | [4.2](/filings/0000064996-26-000020.md) |
| Interest expense | $m | [5.9](/filings/0000064996-23-000034.md) | [7.8 d](/filings/0000064996-24-000002.md) | [7.8](/filings/0000064996-24-000019.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(7.0)](/filings/0000064996-24-000027.md) | [46.6 d](/filings/0000064996-26-000005.md) | [15.8](/filings/0000064996-25-000028.md) | [12.5](/filings/0000064996-25-000041.md) | [56.2](/filings/0000064996-25-000044.md) | [22.4 d](/filings/0000064996-26-000005.md) | [(34.0)](/filings/0000064996-26-000014.md) | [40.3](/filings/0000064996-26-000020.md) | [69.9](/filings/0000064996-25-000044.md) | [46.3 d](/filings/0000064996-26-000005.md) | [45.2](/filings/0000064996-26-000014.md) | [63.8](/filings/0000064996-26-000020.md) |
| Net income | $m | [(8.2)](/filings/0000064996-24-000027.md) | [191 d](/filings/0000064996-26-000005.md) | [73.5](/filings/0000064996-25-000028.md) | [62.6](/filings/0000064996-25-000041.md) | [231](/filings/0000064996-25-000044.md) | [101 d](/filings/0000064996-26-000005.md) | [(108)](/filings/0000064996-26-000014.md) | [166](/filings/0000064996-26-000020.md) | [280](/filings/0000064996-25-000044.md) | [203 d](/filings/0000064996-26-000005.md) | [190](/filings/0000064996-26-000014.md) | [264](/filings/0000064996-26-000020.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0000064996-24-000027.md) | not reported | [1.33](/filings/0000064996-25-000028.md) | [1.13](/filings/0000064996-25-000041.md) | [4.17](/filings/0000064996-25-000044.md) | not reported | [(1.96)](/filings/0000064996-26-000014.md) | [3.01](/filings/0000064996-26-000020.md) | [5.06](/filings/0000064996-25-000044.md) | not reported | [3.44](/filings/0000064996-26-000014.md) | [4.76](/filings/0000064996-26-000020.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0000064996-24-000027.md) | not reported | [1.33](/filings/0000064996-25-000028.md) | [1.13](/filings/0000064996-25-000041.md) | [4.17](/filings/0000064996-25-000044.md) | not reported | [(1.96)](/filings/0000064996-26-000014.md) | [3.01](/filings/0000064996-26-000020.md) | [5.06](/filings/0000064996-25-000044.md) | not reported | [3.44](/filings/0000064996-26-000014.md) | [4.76](/filings/0000064996-26-000020.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000064996-23-000034.md) | [0.6](/filings/0000064996-25-000013.md) | [0.5](/filings/0000064996-24-000019.md) | [0.6](/filings/0000064996-24-000025.md) | [0.6](/filings/0000064996-24-000027.md) | [0.7](/filings/0000064996-26-000005.md) | [1.3](/filings/0000064996-25-000028.md) | [1.1](/filings/0000064996-25-000041.md) | [1.3](/filings/0000064996-25-000044.md) | [1.3](/filings/0000064996-26-000020.md) | [1.4](/filings/0000064996-26-000014.md) | [1.7](/filings/0000064996-26-000020.md) |
| Total assets | $bn | [6.9](/filings/0000064996-23-000034.md) | [7.1](/filings/0000064996-25-000013.md) | [7.4](/filings/0000064996-24-000019.md) | [7.7](/filings/0000064996-24-000025.md) | [8.2](/filings/0000064996-24-000027.md) | [8.3](/filings/0000064996-26-000005.md) | [9.0](/filings/0000064996-25-000028.md) | [9.1](/filings/0000064996-25-000041.md) | [9.4](/filings/0000064996-25-000044.md) | [9.6](/filings/0000064996-26-000020.md) | [9.9](/filings/0000064996-26-000014.md) | [10.5](/filings/0000064996-26-000020.md) |
| Total liabilities | $bn | [5.5](/filings/0000064996-23-000034.md) | [5.6](/filings/0000064996-25-000013.md) | [5.8](/filings/0000064996-24-000019.md) | [6.1](/filings/0000064996-24-000025.md) | [6.3](/filings/0000064996-24-000027.md) | [6.4](/filings/0000064996-26-000005.md) | [7.2](/filings/0000064996-25-000028.md) | [7.1](/filings/0000064996-25-000041.md) | [7.1](/filings/0000064996-25-000044.md) | [7.1](/filings/0000064996-26-000020.md) | [7.3](/filings/0000064996-26-000014.md) | [7.7](/filings/0000064996-26-000020.md) |
| Long-term debt | $bn | not reported | [0.6](/filings/0000064996-24-000002.md) | not reported | not reported | not reported | [0.6](/filings/0000064996-25-000013.md) | not reported | not reported | not reported | [0.6](/filings/0000064996-26-000020.md) | not reported | [0.9](/filings/0000064996-26-000020.md) |
| Shareholders' equity | $bn | [1.4](/filings/0000064996-24-000027.md) | [1.5](/filings/0000064996-26-000005.md) | [1.6](/filings/0000064996-25-000028.md) | [1.6](/filings/0000064996-25-000041.md) | [1.9](/filings/0000064996-25-000044.md) | [1.9](/filings/0000064996-26-000005.md) | [1.8](/filings/0000064996-26-000014.md) | [2.0](/filings/0000064996-26-000020.md) | [2.2](/filings/0000064996-25-000044.md) | [2.4](/filings/0000064996-26-000020.md) | [2.6](/filings/0000064996-26-000014.md) | [2.8](/filings/0000064996-26-000020.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0000064996-24-000027.md) | [225 d](/filings/0000064996-26-000005.md) | [193](/filings/0000064996-25-000028.md) | [278 d](/filings/0000064996-25-000041.md) | [318 d](/filings/0000064996-25-000044.md) | [248 d](/filings/0000064996-26-000005.md) | [(68.7)](/filings/0000064996-26-000014.md) | [372 d](/filings/0000064996-26-000020.md) | [496 d](/filings/0000064996-25-000044.md) | [288 d](/filings/0000064996-26-000005.md) | [326](/filings/0000064996-26-000014.md) | [218 d](/filings/0000064996-26-000020.md) |
| Capital expenditure | $m | [7.9 d](/filings/0000064996-24-000027.md) | [9.8 d](/filings/0000064996-26-000005.md) | [10.3](/filings/0000064996-25-000028.md) | [11.6 d](/filings/0000064996-25-000041.md) | [12.0 d](/filings/0000064996-25-000044.md) | [12.3 d](/filings/0000064996-26-000005.md) | [13.1](/filings/0000064996-26-000014.md) | [14.4 d](/filings/0000064996-26-000020.md) | [16.9 d](/filings/0000064996-25-000044.md) | [14.0 d](/filings/0000064996-26-000005.md) | [16.8](/filings/0000064996-26-000014.md) | [16.1 d](/filings/0000064996-26-000020.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.4](/filings/0000064996-23-000034.md) | [55.4](/filings/0000064996-24-000019.md) | [55.4](/filings/0000064996-24-000025.md) | [55.4](/filings/0000064996-24-000027.md) | [55.4](/filings/0000064996-25-000028.md) | [55.4](/filings/0000064996-25-000041.md) | [55.4](/filings/0000064996-25-000044.md) | [55.4](/filings/0000064996-26-000014.md) | [55.4](/filings/0000064996-26-000020.md) | [55.4](/filings/0000064996-25-000044.md) | [55.4](/filings/0000064996-26-000014.md) | [55.4](/filings/0000064996-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 55,388,627 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0000064996-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.